Literature DB >> 223150

Mechanism for discrimination between viral and host mRNA in interferon-treated cells.

T W Nilsen, C Baglioni.   

Abstract

In extracts of interferon-treated HeLa cells, RNA covalently linked to double-stranded RNA (dsRNA) is preferentially degraded compared with mRNA not linked in dsRNA. This was established by following the degradation of poly(A)-containing mRNA annealed with poly(U), of poly(C)-containing encephalomyocarditis virus RNA annealed with poly(I), and of the replicative intermediate of the virus isolated from infected cells. In extracts of interferon-treated cells, dsRNA promotes the synthesis of a series of oligonucleotides, designated (2'-5')oligo(A), which in turn activate an endonuclease. Several lines of evidence suggest that the (2'-5')oligo(A) polymerase/endonuclease system is involved in the preferential degradation of mRNA linked to dsRNA. Conditions that prevent synthesis of (2'-5')oligo(A) prevent this preferential degradation, whereas addition of (2'-5')oligo(A) or conditions that favor its synthesis result in degradation of mRNA both linked and not linked to dsRNA. These results are best explained by a localized activation of the endonuclease near the dsRNA region of our model substrates. We propose that in infected cells activation of the endonuclease takes place near the replicative intermediates of RNA viruses. The replicative intermediates of encephalomyocarditis virus promote synthesis of (2'-5')-oligo(A) in extracts of interferon-treated cells and are degraded to a 20S "core" resistant to digestion with RNase A. This mechanism may be responsible for discrimination between viral and cellular mRNA in interferon-treated cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223150      PMCID: PMC383655          DOI: 10.1073/pnas.76.6.2600

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Binding of viral and cellular messenger RNAs to ribosomes in eukaryotic cell extracts.

Authors:  L A Weber; M Simili; C Baglioni
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

Review 2.  Antiviral activity of interferons.

Authors:  R M Friedman
Journal:  Bacteriol Rev       Date:  1977-09

3.  Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA.

Authors:  I M Kerr; R E Brown; A G Hovanessian
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

4.  Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells.

Authors:  A G Hovanessian; I M Kerr
Journal:  Eur J Biochem       Date:  1978-03

5.  Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.

Authors:  C Baglioni; M A Minks; P A Maroney
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

6.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

7.  Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase.

Authors:  A Zilberstein; A Kimchi; A Schmidt; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

Authors:  M J Clemens; B R Williams
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

9.  Partial reaction of peptide initiation inhibited by phosphorylation of either initiation factor eIF-2 or 40S ribosomal proteins.

Authors:  G Kramer; A B Henderson; P Pinphanichakarn; M H Wallis; B Hardesty
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor.

Authors:  L A Ball; C N White
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

View more
  44 in total

1.  Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing.

Authors:  J Sperling; J Chebath; H Arad-Dann; D Offen; P Spann; R Lehrer; D Goldblatt; B Jolles; R Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 2.  A scientific journey through the 2-5A/RNase L system.

Authors:  Robert H Silverman
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

3.  An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity.

Authors:  Xiao-Ling Li; Heather J Ezelle; Tae-Jin Kang; Lei Zhang; Kari Ann Shirey; Janette Harro; Jeffrey D Hasday; Saroj K Mohapatra; Oswald R Crasta; Stefanie N Vogel; Alan S Cross; Bret A Hassel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 4.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

5.  Characterization of the products of the U(L)43 gene of herpes simplex virus 1: potential implications for regulation of gene expression by antisense transcription.

Authors:  K L Carter; P L Ward; B Roizman
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Inhibition of binding to initiation complexes of nascent reovirus mRNA by double-stranded RNA-dependent protein kinase.

Authors:  A De Benedetti; G J Williams; C Baglioni
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

Review 7.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

8.  Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells.

Authors:  A P Rice; R Duncan; J W Hershey; I M Kerr
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

9.  Inhibition of viral mRNA translation in interferon-treated L cells infected with reovirus.

Authors:  A De Benedetti; G J Williams; L Comeau; C Baglioni
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Cyclic AMP-dependent regulation of activities of synthetase and phosphodiesterase of 2',5'-oligoadenylate in NIH 3T3 cells.

Authors:  A V Itkes; K T Turpaev; O N Kartasheva; C A Kafiani; E S Severin
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.